AIFF Archives - BioTuesdays

Developments

Firefly builds world’s first 200,000+ EEG/ERP brain scan depository

Firefly Neuroscience (NASDAQ: AIFF) has achieved a major operational and commercial milestone with more than 200,000 EEG/ERP (human brain function) scans. Through its acquisition of Evoke Neuroscience in May 2025...

April 13, 2026

Developments

Firefly confirms public-private partnership with DoW

Firefly Neuroscience (NASDAQ: AIFF) has announced a partnership with the Department of War (DoW) to support the assessment and treatment of active-duty U.S. service members and veterans suffering from post-traumatic...

March 26, 2026

Developments

Firefly announces discovery of new brain wave biomarkers for differential diagnosis of ADHD

Firefly Neuroscience (NASDAQ: AIFF) has announced advancements in research using resting EEG/cognitive EEG (ERP) brain scans, collected on its FDA 510(k)-cleared Evoke System, to potentially distinguish among the three...

March 13, 2026

Developments

Firefly nears launch of NVIDIA-powered human brain model

Firefly Neuroscience (NASDAQ: AIFF) has announced a greater than 20-fold expansion of its commercial footprint, and a 33-fold Increase in its EEG/ERP scan volumes. Through its acquisition of closely held Evoke...

March 4, 2026

Developments

Firefly partners with HealingMaps to offer cognitive electrophysiology analytics to 2500+ clinics across North America

Firefly Neuroscience (NASDAQ: AIFF) announced a new partnership with HealingMaps the leading directory for ketamine, psychedelic-assisted therapy, and transcranial magnetic stimulation (TMS) clinics, and Advanced...

September 5, 2025

Developments

Firefly deploys NVIDIA L40S GPU acceleration to power next-gen CLEAR Platform

Firefly Neuroscience (NASDAQ: AIFF) has announced the unveiling of its new ‘CLEAR’ (CLeaning EEG ARtifacts) Platform, a proprietary next-generation preprocessing technology designed to deliver unrivalled...

August 26, 2025

Developments

Perimeter joins a select group of medtech innovators in the NVIDIA Connect program

In a LinkedIn post today, Perimeter Medical Imaging AI (TSXV:PINK; OTCQX:PYNKF) revealed that it is now a member of the NVIDIA Connect Program. The company joins other medtech innovators that have recently been accepted...

July 30, 2025

Developments

Cognito presents positive Spectris data at AAIC; highlights Firefly collaboration for biomarker discovery using BNA technology

Closely held Cognito Therapeutics has announced five new poster presentations at the Alzheimer’s Association International Conference (AAIC) 2025, supporting the clinical efficacy and neuroprotective mechanism of its...

July 29, 2025

Developments

Firefly’s FDA-cleared BNA platform underpins groundbreaking precision neuroscience study with Heidelberg University

Firefly Neuroscience (NASDAQ: AIFF) has announced its continued collaboration with Prof. Christian Schaaf, MD, Director of the Institute of Human Genetics at Heidelberg University Hospital and Chairman of Human Genetics...

July 14, 2025

Developments

Firefly uncovers powerful new method of measuring SCD, MCI, and dementia in Alzheimer’s disease

Firefly Neuroscience (NASDAQ: AIFF) has announced a significant advancement in Alzheimer’s disease research: the company has identified a novel, objective method for measuring and distinguishing between subjective...

June 20, 2025

Tag - AIFF

Firefly builds world’s first 200,000+ EEG/ERP brain scan depository

Firefly confirms public-private partnership with DoW

Firefly announces discovery of new brain wave biomarkers for differential diagnosis of ADHD

Firefly nears launch of NVIDIA-powered human brain model

Firefly partners with HealingMaps to offer cognitive electrophysiology analytics to 2500+ clinics across North America

Firefly deploys NVIDIA L40S GPU acceleration to power next-gen CLEAR Platform

Perimeter joins a select group of medtech innovators in the NVIDIA Connect program

Cognito presents positive Spectris data at AAIC; highlights Firefly collaboration for biomarker discovery using BNA technology

Firefly’s FDA-cleared BNA platform underpins groundbreaking precision neuroscience study with Heidelberg University

Firefly uncovers powerful new method of measuring SCD, MCI, and dementia in Alzheimer’s disease

Subscribe